Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > EBIT

Rhythm Pharmaceuticals Inc EBIT Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly EBIT from 2016 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Rhythm Pharmaceuticals Inc EBIT for the quarter ending December 12, 2018 was $-27m a 37.38% decrease of -10m year over year
  • Rhythm Pharmaceuticals Inc EBIT for the last 12 months ending December 12, 2018 was $-78m a 45.13% decrease of -35m year over year
  • Rhythm Pharmaceuticals Inc Annual EBIT for 2018 was $-78m a 58.67% decrease of -46m from 2017
  • Rhythm Pharmaceuticals Inc Annual EBIT for 2017 was $-32m a 20.08% decrease of -7m from 2016
  • Rhythm Pharmaceuticals Inc Annual EBIT for 2016 was $-26m a 59.19% decrease of -15m from 2015
Other Income Statement Metrics:
  • Rhythm Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-27m a 37.36% decrease of -10m year over year
  • Rhythm Pharmaceuticals Inc Net Income for the quarter ending September 09, 2018 was $-18m a 40.46% decrease of -7m year over year
View Chart On Koyfin

Quarterly RYTM EBIT Data

12/2018$-27m
09/2018$-19m
06/2018$-15m
03/2018$-17m
12/2017$-11m
09/2017$-8m
06/2017$-7m
03/2017$-6m
12/2016$-8m

Annual RYTM EBIT Data

2018$-78m
2017$-32m
2016$-26m
2015$-11m